Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Colorcon
Argus Health
Fuji
Moodys
Mallinckrodt
Johnson and Johnson
AstraZeneca
McKinsey

Generated: December 18, 2018

DrugPatentWatch Database Preview

CLORAZEPATE DIPOTASSIUM - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for clorazepate dipotassium and what is the scope of clorazepate dipotassium patent protection?

Clorazepate dipotassium is the generic ingredient in four branded drugs marketed by Able, Am Therap, Aurolife Pharma Llc, Dava Pharms Inc, Gd Searle Llc, Mylan, Purepac Pharm, Quantum Pharmics, Usl Pharma, Warner Chilcott, Watson Labs, Recordati Rare, Lederle, Sun Pharm Inds Ltd, Taro Pharm, and Alra, and is included in sixty-two NDAs. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for clorazepate dipotassium. Eight suppliers are listed for this compound.

Pharmacology for CLORAZEPATE DIPOTASSIUM
Drug ClassBenzodiazepine
Medical Subject Heading (MeSH) Categories for CLORAZEPATE DIPOTASSIUM
Synonyms for CLORAZEPATE DIPOTASSIUM
(Chloromethyl)(dimethyl)(tridecyloxy)silane
149128-44-9
1H-1,4-Benzodiazepine-3-carboxylic acid, 7-chloro-2,3-dihydro-2-oxo-5-phenyl-
1H-1,4-Benzodiazepine-3-carboxylic acid, 7-chloro-2,3-dihydro-2-oxo-5-phenyl-, monopotassium salt, compd. with potassium hydroxide
1H-1,4-Benzodiazepine-3-carboxylic acid, 7-chloro-2,3-dihydro-2-oxo-5-phenyl-, monopotassium salt, compd. with potassium hydroxide (K(OH)) (1:1)
1H-1,4-Benzodiazepine-3-carboxylic acid, 7-chloro-2,3-dihydro-2-oxo-5-phenyl-, potassium salt compd. with potassium hydroxide (1:1)
1H-1,4-Benzodiazepine-3-carboxylic acid, 7-chloro-2,3-dihydro-2-oxo-5-phenyl-, potassium salt compound with potassium hydroxide (1:1)
1H-1,4-Benzodiazepine-3-carboxylic acid, 7-chloro-2,3-dihydro-2-oxo-5-phenyl-,monopotassium salt, compd. with potassium hydroxide
1H-1,4-Benzodiazepine-3-carboxylicacid, 7-chloro-2,3-dihydro-2-oxo-5-phenyl-, (-)-
2,5-Dihydroxy-3,6-dichloro-1,4-benzoquinone
20432-69-3
23887-31-2
27665-58-3
28425-34-5
4306 CB
4306-CB
57109-90-7
7-chloro-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepine-3-carboxylic acid
7-chloro-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepine-3-carboxylic acid
7-chloro-2,3-dihydro-2-oxo-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid
7-Chloro-2,3-dihydro-2-oxo-5-phenyl-1H-1,4-Benzodiazepine-3-carboxylic Acid Potassium Salt compd. with Potassium Hydroxide
7-Chloro-2,3-dihydro-2,2-dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid
AB 35616
Abbott 35616
Abbott-35616
AC1L1EIN
AC1L275M
AC1L4ZPM
AC1NQXZQ
AC1Q1TT6
AC1Q3S8C
ACMC-20dcfi
AH 3232
AKOS030242472
Belseren
Bipotassium chlorazepate
C06921
C16H10ClN2O3.HKO.K
CB 4306
Cchlorazepic acid
CHEBI:3761
CHEBI:3762
CHEMBL1213252
CHEMBL2096631
Chlorazepam
Chlorazepate
Chlorazepate Dipotassic
Chlorazepate dipotassium
Chlorazepic acid
clorazepate
Clorazepate acid dipotassium salt
Clorazepate dipotassique
Clorazepate dipotassique [INN-French]
Clorazepate dipotassium (JP17/USP)
Clorazepate Dipotassium [USAN:JAN]
Clorazepate dipotassium [USAN:USP:JAN]
clorazepate potassium
Clorazepato
Clorazepato [DCIT]
Clorazepato dipotasico
Clorazepato dipotasico [INN-Spanish]
Clorazepic acid
Clorazepic acid [BAN]
Clorazepic Acid Dipotasium Salt
CTK0H0237
CTK5A6297
D00694
D0P3JU
DB00628
DEA No. 2768
Dikalii clorazepas
Dikalii clorazepas [INN-Latin]
Dikaliumclorazepat
dipotassium 7-chloro-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepine-3-carboxylate hydroxide
dipotassium 7-chloro-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepine-3-carboxylic acid hydroxide
dipotassium 7-chloro-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepine-3-carboxylate hydroxide
Dipotassium chlorazepate
Dipotassium clorazepate
Dipotassium clorazepate [INN]
DIPOTASSIUM CLORAZEPATE HYDROXIDE
EINECS 245-926-8
EINECS 260-565-6
FT-0665133
Gen-xene
GTPL7548
HE005149
HE061147
HE274088
HE327718
HE354509
HSDB 3041
LS-182361
LS-187760
LS-34023
Mendon
Modiur
Nevracten
Novo-Clopate
Novo-Clopate (TN)
Potassium 7-chloro-2,3-dihydro-2-oxo-5-phenyl-1H-1,4-benzodiazepine-3-carboxylate compound with potassium hydroxide (1:1)
Potassium 7-chloro-2,3-dihydro-2-oxo-5-phenyl-1H-1,4-benzodiazepine-3-carboxylate KOH
Potassium Clorazepate
potassium hydroxide 7-chloro-2-oxo-5-phenyl-2,3-dihydro-1h-1,4-benzodiazepine-3-carboxylate(2:1:1)
QCHSEDTUUKDTIG-UHFFFAOYSA-L
SCHEMBL1649064
Softramal
Tencilan
TR 19119
Transene
Transilium
Tranxene
Tranxene (Cherazepate dipotasium)
Tranxene (TN)
Tranxene /Cherazepate dipotasium/
TRANXENE SD
Tranxene®
Tranxilen
Tranxilene
Tranxilium
XDDJGVMJFWAHJX-UHFFFAOYSA-N

US Patents and Regulatory Information for CLORAZEPATE DIPOTASSIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Am Therap CLORAZEPATE DIPOTASSIUM clorazepate dipotassium TABLET;ORAL 071748-001 Jun 23, 1987 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Recordati Rare TRANXENE clorazepate dipotassium CAPSULE;ORAL 017105-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan CLORAZEPATE DIPOTASSIUM clorazepate dipotassium CAPSULE;ORAL 071511-001 Oct 19, 1987 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Purepac Pharm CLORAZEPATE DIPOTASSIUM clorazepate dipotassium CAPSULE;ORAL 071925-001 Apr 25, 1988 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sun Pharm Inds Ltd CLORAZEPATE DIPOTASSIUM clorazepate dipotassium TABLET;ORAL 076911-003 Sep 29, 2004 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for CLORAZEPATE DIPOTASSIUM

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Recordati Rare TRANXENE clorazepate dipotassium TABLET;ORAL 017105-007 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Recordati Rare TRANXENE clorazepate dipotassium CAPSULE;ORAL 017105-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Recordati Rare TRANXENE SD clorazepate dipotassium TABLET;ORAL 017105-005 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Recordati Rare TRANXENE clorazepate dipotassium TABLET;ORAL 017105-008 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Recordati Rare TRANXENE clorazepate dipotassium TABLET;ORAL 017105-006 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Colorcon
Argus Health
Fuji
Moodys
Mallinckrodt
Johnson and Johnson
AstraZeneca
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.